Biden urges businesses mandate COVID-19 vaccine following full approval of the Pfizer-BioNTech shot
President Biden leaned into the new FDA licensure, or full approval, of the Pfizer-BioNTech COVID-19 vaccine on Monday, encouraging businesses to require vaccinations among employees.
FDA approves Pfizer's COVID-19 shot: What is licensure?
Federal regulators issued full approval to the Pfizer-BioNTech COVID-19 vaccine on Monday following rigorous review and independent analyses of data submitted through a biologics license application.
Trillium Therapeutics shares soar on Pfizer’s $2.26B deal
Pfizer's $2.26B Trillium deal will target drugs for blood cancers, such as leukemia, multiple myeloma and lymphoma, according to the companies.
When ransomware gets deadly: Attack brings down hospital system
A Marietta, Ohio-based hospital chain was recently forced to shut down IT systems and cancel surgeries, underscoring the deadly ramifications of ransomware.
Johnson & Johnson CEO stepping down in January
Joaquin Duato, the vice chairman of Johnson & Johnson’s executive committee, will step up as the company’s next CEO and a member of its board of directors effective Jan. 3, 2022. Alex Gorsky, the current CEO, is stepping down.
Purdue hoped tamper-resistant OxyContin could help opioid crisis, owner testifies
The family that owns Purdue Pharma had hoped a reformulated version of Oxycontin would help rein in the burgeoning opioid crisis a decade ago, a member of the Sackler family said Thursday in court testimony that once again stopped short of an apology or acceptance of responsibility for the epidemic.
Purdue Pharma ex-head Richard Sackler denies responsibility for opioid crisis
The former president and board chair of Purdue Pharma told a court Wednesday that he, his family and the company are not responsible for the opioid crisis in the United States.
Moderna stock cements lead as S&P 500's top performer of 2021
Moderna is the star stock of 2021 maintaining its position as the S&P 500’s top performer.
Bayer takes legal battle over Roundup cancer claims to US Supreme Court
Bayer, trying to contain billions of dollars in legal costs, filed a petition with the U.S. Supreme Court to reverse an appeals court verdict that upheld damages to a customer blaming his cancer on the German group's glyphosate-based weedkillers.
NYSE requires COVID vaccinations to access trading floor
The NYSE has updated its vaccine policy for visitors to its iconic trading floor.
Pfizer COVID-19 vaccine full approval projected for September
The Food and Drug Administration (FDA) will weigh full approval of Pfizer’s COVID-19 vaccine by a projected goal of September, sources within the agency confirmed to Fox News.
BeyondSpring stock soars after lung cancer drug combo boosts overall survival
Global pharmaceutical company BeyondSpring announced positive findings in a late-stage trial of a drug combo to treat second- and third-line nonsmall cell lung cancer.
Citi, HSBC, Prudential hatch plan for Asian coal-fired closures -sources
Financial firms including British insurer Prudential, lenders Citi and HSBC and BlackRock Real Assets are devising plans to speed the closure of Asia’s coal-fired power plants in order to lower the biggest source of carbon emissions, five people with knowledge of the initiative said.
St. Louis mask mandate faces lawsuit from state official: 'It's not based on science'
Eric Schmitt, attorney general for the state of Missouri, has filed a lawsuit against the City of St. Louis for reinstating a mask mandate. The city’s mandate comes as the Centers for Disease Control and Prevention is set to recommend Tuesday that some vaccinated individuals resume wearing masks in certain situations to protect against COVID-19, reversing its earlier guidance that only unvaccinated individuals should wear face coverings.
Tobacco-maker Philip Morris to end selling traditional cigarettes in UK over next 10 years
A major cigarette company has announced its intention to end sales in the United Kingdom in 10 years’ time.
US population growth, an economic driver, grinds to a halt
America’s weak population growth, already held back by a decadelong fertility slump, is dropping closer to zero because of the Covid-19 pandemic.
Scripps Health employee allegedly stole dead COVID patients' identities to access government benefits: report
A former Scripps Health employee is charged with stealing the personal information of dying patients for use in filing fraudulent benefits claims.
Johnson & Johnson forecasts $2.5B of coronavirus vaccine sales
Johnson & Johnson said it will sell $2.5 billion worth of its COVID-19 vaccine this year and pushed back against concerns over its effectiveness against the delta variant.
Moderna being added to S&P 500
COVID-19 vaccine leader Moderna is joining the big leagues.
FDA targets January for Pfizer COVID-19 vaccine full approval decision
The Food and Drug Administration (FDA) will weigh full approval for the Pfizer-BioNTech COVID-19 vaccine in people aged 16 and older by January, the companies announced Friday.



















